Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

86.01
+4.665.73%
Post-market: 84.50-1.5100-1.76%18:07 EDT
Volume:1.14M
Turnover:98.44M
Market Cap:5.58B
PE:-6.11
High:87.79
Open:81.01
Low:81.01
Close:81.35
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.15
T/O Rate:2.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-535.87
PE(LYR):-183.00

Loading ...

Mirum plans USD 600 million convertible senior notes offering due 2032

Reuters
·
May 13

Mirum Pharmaceuticals Inc - Initial Purchasers May Buy up to $90 Mln Additional Notes

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Inc - Notes to Mature on June 1, 2032

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals to present at H.C. Wainwright BioConnect investor conference

Reuters
·
May 12

RBC Capital Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
May 07

Mirum Pharmaceuticals Is Maintained at Outperform by Baird

Dow Jones
·
May 07

Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q1 Loss $13.43 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
May 07

Mirum Q1 FY26 operating loss widens to $789.47 million; revenue rises 43.3% to $159.88 million

Reuters
·
May 07

Mirum Pharmaceuticals Q1 EPS $(13.43) Misses $(0.37) Estimate, Sales $159.882M Beat $149.535M Estimate

Benzinga Earnings
·
May 07

BRIEF-Mirum Pharmaceuticals Q1 Product Sales USD 159.882 Million

Reuters
·
May 07

Mirum Pharmaceuticals Inc - Raises 2026 Net Product Sales Guidance to $660-$680 Mln

THOMSON REUTERS
·
May 07

Mirum Pharmaceuticals Q1 Operating Income USD -789.465 Million

THOMSON REUTERS
·
May 07

Mirum Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 06

Mirum Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 05

BUZZ-U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx

Reuters
·
May 05

Shares of Mirum Pharmaceuticals Hit All-Time High on Phase 2B Results for Liver Treatment

Dow Jones
·
May 04

Mirum Pharmaceuticals price target raised to $175 from $150 at H.C. Wainwright

TIPRANKS
·
May 04

Mirum Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $175 From $150

THOMSON REUTERS
·
May 04

Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
May 04